[
18
F]FDG-PET for evaluating pediatric Rosai-Dorfman disease
Pediatr Hematol Oncol
.
2018 Apr;35(3):177-180.
doi: 10.1080/08880018.2018.1484828.
Epub 2018 Oct 22.
Authors
Nicholas S Whipple
1
,
Laura L Marion
2
,
David M Dansie
3
,
Andrea T Murina
4
,
Gail C Megason
5
,
Vani Vijayakumar
6
,
Betty L Herrington
5
Affiliations
1
a Division of Hematology/Oncology, Department of Pediatrics , University of Utah and Primary Children's Hospital , Salt Lake City , Utah , USA.
2
b Physicians and Surgeons Clinic, Columbus, Mississippi, USA.
3
c Department of Radiology , Primary Children's Hospital , Salt Lake City , Utah , USA.
4
d Department of Dermatology , Tulane University School of Medicine , New Orleans , Louisiana , USA.
5
e Division of Pediatric Hematology/Oncology, Department of Pediatrics , University of Mississippi Medical Center , Jackson , Mississippi , USA.
6
f Department of Radiology , University of Mississippi Medical Center , Jackson , Mississippi , USA.
PMID:
30346866
DOI:
10.1080/08880018.2018.1484828
No abstract available
Publication types
Case Reports
MeSH terms
Adolescent
Female
Fluorodeoxyglucose F18 / metabolism*
Histiocytosis, Sinus / diagnosis*
Histiocytosis, Sinus / diagnostic imaging*
Histiocytosis, Sinus / pathology
Humans
Positron-Emission Tomography / methods*
Substances
Fluorodeoxyglucose F18